Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2009Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulationDegenhardt, L.; Larance, B.; Bell, J.; Winstock, A.; Lintzeris, N.; Ali, R.; Scheuer, N.; Mattick, R.
2005Short-term outcomes of five heroin detoxification methods in the Australian NEPOD projectDigiusto, E.; Lintzeris, N.; Breen, C.; Kimber, J.; Mattick, R.; Bell, J.; Ali, R.; Saunders, J.
1999A study on the seasonal variation in the development of morphine dependence in rats.Salem, A.; Hope, W.
2009The acceptability, safety, and tolerability of methadone/naloxone in a 50:1 ratioBell, J.; Shearer, J.; Ryan, A.; Graham, R.; Korompay, K.; Rizzo, S.; Sindhusake, D.; Somogyi, A.
1999Role of endogenous adenosine in the expression of opiate withdrawal in rats.Salem, A.; Hope, W.
2008Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjectsLa Vincente, S.; White, J.; Somogyi, A.; Bochner, F.; Chapleo, C.
2012Opioid activation of toll-like receptor 4 contributes to drug reinforcementHutchinson, M.; Northcutt, A.; Hiranita, T.; Wang, X.; Lewis, S.; Thomas, J.; van Steeg, K.; Kopajtic, T.; Loram, L.; Sfregola, C.; Galer, E.; Miles, N.; Bland, S.; Amat, J.; Rozeske, R.; Maslanik, T.; Chapman, T.; Strand, K.; Fleshner, M.; Bachtell, R.; et al.
2002In vivo and in vitro potency studies of 6b-naltrexol, the major human metabolite of naltrexonePorter, S.; Somogyi, A.; White, J.